Home » Arthritis Symptoms » Septic Arthritis Symptoms
Septic Arthritis Symptoms
Enbrel: FDA Approval In The Treatment Of Juvenile Rheumatoid Arthritis
For children, under age 16, who suffer from arthritic related symptoms greater than six weeks, the complication is often believed to be attributed to the development of juvenile rheumatoid arthritis. Each year, many children are diagnosed with this life changing condition. As parents, understanding the use of the FDA approved drug, Enbrel, in the treatment of juvenile rheumatoid arthritis, the side effects, dosing and the contraindications, may provide for a more educated process when determining the method or route of healthcare to be administered to your child.
Enbrel, manufactured by Immunex Corporation, is an FDA approved drug used to treat the symptoms associated with active juvenile rhuematoid arthritis including the associated joint and physiological deterioration. Lending its primary success to the reduction of inflammation, swelling and tenderness in joints, Enbrel may be the key injection to reducing significant pain factors associated with juvenile rheumatoid arthritis thereby increasing joint movement and mobility in children. As with any childhood disorder, diagnosing the condition early and administering aggressive treatment, may ensure the most optimal outcome. As an injection, Enbrel is administered in children suffering from juvenile rheumatoid arthritis once or twice weekly at a dosing level of 0.4 milligrams of drug per kilogram of child body weight. The maximum dosing, however, is subject to the recommended adult dosing of 25 milligrams per injection. The benefit of Enbrel, following adminstration of the injection, can be seen as early as two weeks with benefits continuing up to three months. As with any prescribed medication, Enbrel does come with side effects and contraindications in the treatment of juvenile rheumatoid arthritis. For children suffering from juvenile rheumatoid arthritis, comorbid for central nervous system disorders, Enbrel is not an appropriate form of treatment. Additionally, for teenage girls who may be sexually active, Enbrel should not be used due to the lack of research in the health implicattions Enbrel may have on a fetus. Additionally, Enbrel, in the treatment of juvenile rheumatoid arthritis, may impede the heaing process of wounds. As a result, Enbrel, is contraindicated in patients comorbid with diabetes or in patients with a general compromised immune system due to immunosuppressive diseases. For children suffering from juvenile rheumatoid arthritis, obtaining symptom relief is a primary concern for both parents as well as healthcare professionals. With the introduction of Enbrel, once or twice weekly, statistics have shown three out of four juvenile rheumatoid arthritis children will not only experience relief of symptoms but will obtain benefits in improved structural bone improvement. With the administration of Enbrel, twice weekly, juvenile rheumatoid arthritis associated symptoms are alleviated allowing the child to return to activities of daily living. For more information regarding the use of Enbrel in the treatment of juvenile rheumatoid arthritis, visit www.enbrel.com.By Christine Cadena - Website content writer, specializing in website content related to travel, health, and legal issues. Also specializing in blog marketing and social media marketing.
What is Arthritis Rheumatoid Arthritis Causes Treatments and Symptoms Pain Re
22 Jan 2010 at 8:13am
Next page: Rheumatoid Arthritis Symptoms
Bookmark/Share This Page:
|
|
|
|
Septic Arthritis Symptoms News
Moving against arthritis - Tulsa World
20 May 2012 at 2:27am On May 9, 1863, only 10 months after enlisting in the Missouri Militia, Cpl. James N. DelCour lost his job as a wagon driver supplying Union troops in southeast Missouri. The young teamster in Company B of the 32nd Regiment was deemed "unfit ...Read more...
Managing arthritis, fall prevention May 25 - Morning Sentinel
19 May 2012 at 10:38pm WATERVILLE -- Marci Lowe, from Inland Rheumatology, will speak about arthritis pain management and fall prevention in recognition of National Arthritis Month at 1 p.m. Friday at Spectrum Generations Muskie Center. To register for the free event ...Read more...
FDA panel favors novel arthritis drug from Pfizer - Yahoo Finance
19 May 2012 at 5:01pm WASHINGTON (AP) -- Federal health advisers said Wednesday that a first-of-a-kind drug from Pfizer appears to be safe and effective for patients with rheumatoid arthritis, though they recommended follow-up studies to gauge the pill's long-term ...Read more...
